Giat E, Ben-Zvi I, Lidar M, Livneh A
Int J Mol Sci. 2022; 23(7).
PMID: 35409316
PMC: 8999740.
DOI: 10.3390/ijms23073956.
Vinit C, Georgin-Lavialle S, Theodoropoulou A, Barbier C, Belot A, Mejbri M
Front Immunol. 2021; 12:744780.
PMID: 34858402
PMC: 8632237.
DOI: 10.3389/fimmu.2021.744780.
Cudrici C, Deuitch N, Aksentijevich I
Int J Mol Sci. 2020; 21(9).
PMID: 32380704
PMC: 7246474.
DOI: 10.3390/ijms21093263.
Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J
Inflamm Regen. 2019; 39:12.
PMID: 31182982
PMC: 6551897.
DOI: 10.1186/s41232-019-0101-5.
Quintero J, Saba J, Garcia C
Cureus. 2019; 11(1):e3916.
PMID: 30931187
PMC: 6426556.
DOI: 10.7759/cureus.3916.
Anakinra Therapy for Non-cancer Inflammatory Diseases.
Cavalli G, Dinarello C
Front Pharmacol. 2018; 9:1157.
PMID: 30459597
PMC: 6232613.
DOI: 10.3389/fphar.2018.01157.
Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.
Van Gorp H, Van Opdenbosch N, Lamkanfi M
Cold Spring Harb Perspect Biol. 2017; 11(1).
PMID: 29038114
PMC: 6314066.
DOI: 10.1101/cshperspect.a028563.
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.
Fenini G, Contassot E, French L
Front Pharmacol. 2017; 8:278.
PMID: 28588486
PMC: 5438978.
DOI: 10.3389/fphar.2017.00278.
New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.
Xu B, Harb S, Cremer P
Curr Cardiol Rep. 2017; 19(7):60.
PMID: 28528454
DOI: 10.1007/s11886-017-0866-6.
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
Gattorno M, Obici L, Cattalini M, Tormey V, Abrams K, Davis N
Ann Rheum Dis. 2016; 76(1):173-178.
PMID: 27269295
PMC: 5264215.
DOI: 10.1136/annrheumdis-2015-209031.
Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.
van der Hilst J, Moutschen M, Messiaen P, Lauwerys B, Vanderschueren S
Biologics. 2016; 10:75-80.
PMID: 27110096
PMC: 4831592.
DOI: 10.2147/BTT.S102954.
The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review.
Baskar S, Klein A, Zeft A
Cardiol Res Pract. 2016; 2016:7840724.
PMID: 26942035
PMC: 4752980.
DOI: 10.1155/2016/7840724.
[Translational research in pediatric rheumatology. Current research approaches to the innate immune system].
Lippitz K, Waldkirch J, Kessel C, Varga G, Foell D
Z Rheumatol. 2016; 75(3):276-83.
PMID: 26800663
DOI: 10.1007/s00393-015-0040-8.
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
Cavalli G, Dinarello C
Rheumatology (Oxford). 2015; 54(12):2134-44.
PMID: 26209330
PMC: 5009422.
DOI: 10.1093/rheumatology/kev269.
From bench to bedside and back again: translational research in autoinflammation.
Holzinger D, Kessel C, Omenetti A, Gattorno M
Nat Rev Rheumatol. 2015; 11(10):573-85.
PMID: 26077920
DOI: 10.1038/nrrheum.2015.79.
Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
La Torre F, Muratore M, Vitale A, Moramarco F, Quarta L, Cantarini L
Rheumatol Int. 2015; 35(11):1943-7.
PMID: 26048626
DOI: 10.1007/s00296-015-3305-2.
Current knowledge on procaspase-1 variants with reduced or abrogated enzymatic activity in autoinflammatory disease.
Luksch H, Winkler S, Heymann M, Schulze F, Hofmann S, Roesler J
Curr Rheumatol Rep. 2015; 17(7):45.
PMID: 26003867
DOI: 10.1007/s11926-015-0520-5.
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.
Lopalco G, Cantarini L, Vitale A, Iannone F, Anelli M, Andreozzi L
Mediators Inflamm. 2015; 2015:194864.
PMID: 25784780
PMC: 4345261.
DOI: 10.1155/2015/194864.
An expanding role for interleukin-1 blockade from gout to cancer.
Dinarello C
Mol Med. 2014; 20 Suppl 1:S43-58.
PMID: 25549233
PMC: 4374514.
DOI: 10.2119/molmed.2014.00232.
Treating inflammation by blocking interleukin-1 in humans.
Dinarello C, van der Meer J
Semin Immunol. 2013; 25(6):469-84.
PMID: 24275598
PMC: 3953875.
DOI: 10.1016/j.smim.2013.10.008.
